Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Lancet HIV. 2021 Jan;8(1):e33–e41. doi: 10.1016/S2352-3018(20)30268-X

Table 3.

Birth outcomes of periconceptionally DTG- and EFV- exposed women, Brazil, 2015-2018.

Only EFV regimen
(N=1068)
Any DTG regimen
(N=384)
P valuea
Birth outcomes
Neural tube defects, n (%) 0 (0) 0 (0) -
Outcome 0·0037
 Live birth 1025 (96) 359 (93)
 Stillbirth 15 (1) 2 (1)
 Abortion 28 (3) 23 (6)
Fetus number 0·014
 Singleton 1024 (96) 380 (99)
 Twin 38 (3) 4 (1)
 Triplet 6 (1) 0 (0)
Sex, Gestational Age & Anthropometries
Male sexb 526 (51) 172 (48) 0·24
Gestational age at delivery in weeksc,median [IQR] 39 [38-39] 39 [38-39] 0·85
Birth weightd (grams) 3048 [2740-3365] 3012 [2748-3310] 0·44
Other congenital birth defectse
Any congenital abnormality 59 (6) 18 (5) 0·53
Polydactyly 1 (0) 1 (0) 0·45
Talipes equinovarus 4 (0) 0 (0) 0·23
Cleft palate 0 (0) 2 (1) 0·018
Cardiac birth defect 5 (0) 1 (0) 0·59
Digestive system birth defects 3 (0) 0 (0) 0·30
Urinary system birth defects 0 (0) 1 (0) 0·095
Genitalia abnormality 2 (0) 1 (0) 0·79
Other birth defects 4 (0) 1 (0) 0·74
a

Continuous variables examined using Wilcoxon rank-sum test and categorical variables examined using Chi square test of proportions.

b

Sex data available for 1384 infants.

c

Gestational age at delivery data available for 1321 infants.

d

Birth weight data available for 1363 infants.

e

Congenital defects as recorded in any birth outcome.

Abbreviations used:

EFV: efavirenz

DTG: dolutegravir

ART: antiretroviral therapy

IQR: interquartile range